1. Alternative donors for allogeneic hematopoietic stem cell transplantation in poor-risk AML in CR1
by Jurjen Versluis, Myriam Labopin, Annalisa Ruggeri, Gerard Socie, Depei Wu, Liisa Volin, Didier Blaise, Noel Milpied, Charles Craddock, Ibrahim Yakoub-Agha, Johan Maertens, Per Ljungman, Anne Huynh, Mauricette Michallet, Eric Deconinck, Patrice Chevallier, Jakob Passweg, Fabio Ciceri, Mohamad Mohty, Jan J. Cornelissen, and Arnon Nagler
BloodAdv
Volume 1(7):
February 28, 2017
© 2017 by The American Society of Hematology

2. Jurjen Versluis et al. Blood Adv 2017;1:477-485
© 2017 by The American Society of Hematology

3. Outcome by different donor types.
Outcome by different donor types. Kaplan-Meier estimates of OS (A), RFS (B), relapse (C), and NRM (D) by donor type of patients with poor-risk AML in CR1. F, number of failures (ie, death whatever the cause); Cox LR, Cox likelihood ratio.
Jurjen Versluis et al. Blood Adv 2017;1:
© 2017 by The American Society of Hematology